LEVETIRACETAM DEXCEL 250

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

LEVETIRACETAM

متاح من:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC رمز:

N03AX14

الشكل الصيدلاني:

TABLETS

تركيب:

LEVETIRACETAM 250 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

DEXCEL LTD, ISRAEL

المجموعة العلاجية:

LEVETIRACETAM

المجال العلاجي:

LEVETIRACETAM

الخصائص العلاجية:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

تاريخ الترخيص:

2018-03-31